The stock of AlloVir Inc (NASDAQ: ALVR) has increased by 11.60 when compared to last closing price of 0.89.Despite this, the company has seen a gain of 10.79% in its stock price over the last five trading days. globenewswire.com reported 2024-09-16 that NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of AlloVir, Inc. (NASDAQ: ALVR) breached their fiduciary duties to shareholders.
Is It Worth Investing in AlloVir Inc (NASDAQ: ALVR) Right Now?
The stock has a 36-month beta value of 0.74. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 2 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ALVR is 58.15M, and at present, short sellers hold a 8.42% of that float. On November 06, 2024, the average trading volume of ALVR was 192.44K shares.
ALVR’s Market Performance
The stock of AlloVir Inc (ALVR) has seen a 10.79% increase in the past week, with a 23.75% rise in the past month, and a 37.11% gain in the past quarter. The volatility ratio for the week is 15.43%, and the volatility levels for the past 30 days are at 9.24% for ALVR. The simple moving average for the past 20 days is 18.21% for ALVR’s stock, with a 29.89% simple moving average for the past 200 days.
Analysts’ Opinion of ALVR
Many brokerage firms have already submitted their reports for ALVR stocks, with BofA Securities repeating the rating for ALVR by listing it as a “Underperform.” The predicted price for ALVR in the upcoming period, according to BofA Securities is $1 based on the research report published on December 26, 2023 of the previous year 2023.
ALVR Trading at 23.78% from the 50-Day Moving Average
After a stumble in the market that brought ALVR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.16% of loss for the given period.
Volatility was left at 9.24%, however, over the last 30 days, the volatility rate increased by 15.43%, as shares surge +24.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +26.80% upper at present.
During the last 5 trading sessions, ALVR rose by +10.79%, which changed the moving average for the period of 200-days by +45.55% in comparison to the 20-day moving average, which settled at $0.8374. In addition, AlloVir Inc saw 45.62% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALVR starting from Brainard Diana, who proposed sale 10,609 shares at the price of $0.86 back on Nov 05 ’24. After this action, Brainard Diana now owns shares of AlloVir Inc, valued at $9,176 using the latest closing price.
Miller Edward, the Officer of AlloVir Inc, proposed sale 2,272 shares at $0.86 during a trade that took place back on Nov 05 ’24, which means that Miller Edward is holding shares at $1,965 based on the most recent closing price.
Stock Fundamentals for ALVR
Current profitability levels for the company are sitting at:
- -14.43 for the present operating margin
- 0.55 for the gross margin
The net margin for AlloVir Inc stands at -16.75. The total capital return value is set at -0.94. Equity return is now at value -80.33, with -67.85 for asset returns.
Based on AlloVir Inc (ALVR), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at -13.43. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is -59.03.
Currently, EBITDA for the company is -180.93 million with net debt to EBITDA at 0.79. When we switch over and look at the enterprise to sales, we see a ratio of 2.2. The receivables turnover for the company is 87.29for trailing twelve months and the total asset turnover is 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 55.08.
Conclusion
To sum up, AlloVir Inc (ALVR) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
